Page 3 - Rod Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

One of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells are the cone cells, so they exist in this kind of mosaic. early results of using gene therapy to treat retinitis pigmentosa has shown that it could potentially not only slow the progression of the disease, but, in some cases, reverse some of its effects. the work being done here has real potential to change the lives of people with inherited...

So we and others, over the last five to ten years, have developed a new viral vector, and we're manufacturing that here to deliver the genes we're delivering into the body. in addition, at meira, we've actually developed over the last seven years a totally new technology which allows us to, in the future, control how those genes that are delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detecting cells in the retina to break down over time, causing a person to ...

Here to deliver the genes we're delivering into the body. in addition, at meira, we've actually developed over the last seven years a totally new technology which allows us to, in the future, control how those genes that are delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells are the cone cells, so they exist in this kind of mosaic. early resul...

A whitepaper discussing the hallmarks of cancer

Gene therapy shows promise in initial trial for patients with childhood blindness: Study ANI | Updated: Apr 20, 2021 17:11 IST Philadelphia (Pennsylvania) [US], April 20 (ANI): A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers. The novel study was led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania. The therapy delivers working copies of GUCY2D to the eyes of pa...